文献速递胸部肿瘤

20包年以上吸烟史者戒烟15年后肺癌诊断与死亡的系统综述

Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: A systematic review.
PubMed 文献 · CA Cancer J Clin · 2023-11-01

该系统综述检索PubMed与Scopus至2023年2月14日,纳入22项研究,评估吸烟史≥20包年且戒烟≥15年人群的肺癌 incidence、风险与死亡率。低 certainty 证据提示戒烟15年后肺癌 incidence 仍高于从不吸烟者;中等 certainty 证据提示戒烟15年后肺癌诊断风险逐渐下降,但15年前后无临床显著差异。研究提示戒烟15年后结局在非裔美国黑人 vs 白人参与者中相似;延长戒烟年限会扩大非裔美国黑人的合格性,但对白人扩大比例更大。

要点

  • 低 certainty 证据提示戒烟≥15年后肺癌 incidence 仍高于从不吸烟者。
  • 中等 certainty 证据提示戒烟15年后肺癌诊断风险逐渐下降,但15年前后无临床显著差异。
  • 戒烟15年后结局在非裔美国黑人 vs 白人参与者中相似;延长戒烟年限扩大合格性对白人比例更大。

核心结论

  • 作者观察到肺癌风险不仅持续超过戒烟15年,而且与从不吸烟者相比,风险可能在2或3个十年内仍显著升高。

研究设计与样本

  • 系统综述,检索PubMed与Scopus至2023年2月14日,并手工检索相关文章;从2636条题录中纳入22项研究(26篇文章)。
  • 由一名研究者摘录数据、第二名研究者确认;两名研究者独立评估研究质量与证据 certainty(COE),通过共识解决分歧。
  • 纳入研究考察吸烟史≥20包年且戒烟≥15年的成人中肺癌诊断、死亡率与筛查不合格性的关系。

主要发现

  • 三项研究提供低 COE:与从不吸烟者相比,戒烟超过15年后肺癌 incidence 升高。
  • 六项研究提供中等 COE:戒烟15年后肺癌诊断风险逐渐下降,但15年前后无临床显著差异。
  • 研究提示戒烟15年后结局在非裔美国黑人 vs 白人参与者中相似;延长戒烟年限会扩大非裔美国黑人的合格性,但对白人扩大比例显著更大。

局限性

  • 需要未来开展全国代表性样本且研究间报告一致的研究。
  • 需要更好的数据来考察对不同人群健康差异的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current US lung cancer screening recommendations limit eligibility to adults with a pack-year (PY) history of ≥20 years and the first 15 years since quit (YSQ). The authors conducted a systematic review to better understand lung cancer incidence, risk and mortality among otherwise eligible individuals in this population beyond 15 YSQ. The PubMed and Scopus databases were searched through February 14, 2023, and relevant articles were searched by hand. Included studies examined the relationship between adults with both a ≥20-PY history and ≥15 YSQ and lung cancer diagnosis, mortality, and screening ineligibility. One investigator abstracted data and a second confirmed. Two investigators independently assessed study quality and certainty of evidence (COE) and resolved discordance through consensus. From 2636 titles, 22 studies in 26 articles were included. Three studies provided low COE of elevated lung cancer incidence beyond 15 YSQ, as compared with people who never smoked, and six studies provided moderate COE that the risk of a lung cancer diagnosis after 15 YSQ declines gradually, but with no clinically significant difference just before and after 15 YSQ. Studies examining lung cancer-related disparities suggest that outcomes after 15 YSQ were similar between African American/Black and White participants; increasing YSQ would expand eligibility for African American/Black individuals, but for a significantly larger proportion of White individuals. The authors observed that the risk of lung cancer not only persists beyond 15 YSQ but that, compared with individuals who never smoked, the risk may remain significantly elevated for 2 or 3 decades. Future research of nationally representative samples with consistent reporting across studies is needed, as are better data from which to examine the effects on health disparities across different populations.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Kondo KK, Rahman B, Ayers CK, et al. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: A systematic review. CA Cancer J Clin. 2023. PMID: 37909870. doi:10.3322/caac.21808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。